Silence Therapeutics appoints Chief Medical Officer, shares rise

Silence Therapeutics has unveiled Michael Khan as the company's new Chief Medical Officer.

Silence Therapeutics has unveiled Michael Khan as the company's new Chief Medical Officer.

He will oversee the phase II study on ATU027 for cancer and aid in the expansion of the private biotechnology company's clinical pipelines in oncology and acute lung injury.

Khan is a consultant endocrinologist at University Hospitals of Coventry and Warwickshire. He is also an associate professor of medicine at the University of Warwick.

Last September he became a director and chief medical adviser at Silence Therapeutics, which develops systematic RNA interference therapeutics for the treatment of cancer and other diseases.

"These are very exciting times for Silence Therapeutics, with one oncology drug advancing to phase II," he said in a statement.

"Moreover, with a range of new indications in the pipeline, I am really happy to be a part of this dynamic new enterprise."

Ali Mortazavi, director of Corporate Strategy, added: "I'm delighted Mike has decided to devote more time to us. Next year will be pivotal for Silence after so many years spent preparing for phase II trials."

Shares jumped 9.71% to 4.80p at 12:39 Wednesday.

RD

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

How the stamp duty holiday is pushing up house prices
Stamp duty

How the stamp duty holiday is pushing up house prices

Stamp duty is an awful tax and should be replaced by something better. But its temporary removal is driving up house prices, says Merryn Somerset Webb…
25 Sep 2020
Can Rishi Sunak’s winter plan save the UK economy?
UK Economy

Can Rishi Sunak’s winter plan save the UK economy?

With his Winter Economic Plan, chancellor Rishi Sunak is hoping to support the economy through the dark months ahead as restrictions tighten again. Jo…
25 Sep 2020
The electric-car bubble could get an awful lot bigger from here
Renewables

The electric-car bubble could get an awful lot bigger from here

The switch to electric cars is driving a huge investment bubble. But that’s not necessarily a bad thing, says John Stepek. Fortunes will be made and l…
24 Sep 2020